Tag: Kineta Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Kineta Inc.

Kineta Presents New Preclinical Data at ESMO Virtual Congress 2020 on its VISTA Antagonist ...

Added to Collection on: 2020-12-09 13:18:45

Tags for this article:

Medical specialties
Clinical medicine
Branches of biology
Immunology
Immune system
VISTA
Tumor microenvironment
Cancer immunotherapy
T cell
Immunotherapy
Antibody
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta Presenting at Multiple Investor Conferences in March 2021

Added to Collection on: 2021-03-03 12:45:00

Tags for this article:

Communication
Forward-looking statement
Kineta
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta to Participate in "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond ...

Added to Collection on: 2021-06-07 12:33:45

Tags for this article:

Immune system
Branches of biology
Clinical medicine
Medical specialties
Cancer immunotherapy
Clusters of differentiation
VISTA
Immune checkpoint
PD-L1
Tumor microenvironment
Programmed cell death protein 1
Myeloid-derived suppressor cell
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta Announces Successful Completion of Pre-IND Meeting with the FDA for KVA12.1

Added to Collection on: 2021-07-27 12:33:45

Tags for this article:

Health sciences
Health
Clinical research
Food and Drug Administration
Pharmaceutical industry
Drug discovery
Drug safety
Investigational New Drug
Drug development
Pembrolizumab
Clinical trial
Cancer immunotherapy
Kineta Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Kineta Presents Preclinical Data on Its New CD27 Program at the AACR Conference on ...

Added to Collection on: 2021-10-09 08:37:30

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immune system
CD27
Cancer immunotherapy
Immunotherapy
Monoclonal antibody
Cancer immunology
Natural killer cell
CD70
Immune checkpoint
Thierry Guillaudeux
Kineta Inc.
Kineta

Click the tags to see associated articles and topics

View Article Details
Kineta Presented Compelling Preclinical Data on its New CD27 Antibody Program at the ...

Added to Collection on: 2021-11-16 14:49:21

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immune system
Immunology
Biotechnology
Cancer immunotherapy
Immune checkpoint
Cancer treatments
CD27
Monoclonal antibody
Immunotherapy
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta to Present at the H.C. Wainwright Bioconnect Virtual Conference | News | khq.com

Added to Collection on: 2022-01-11 14:01:30

Tags for this article:

Acropolis Rally
Kineta
Immunotherapy
Forward-looking statement
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022

Added to Collection on: 2022-04-13 18:28:57

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Immune system
CD27
Cancer immunotherapy
Biotechnology
Immunotherapy
Monoclonal antibody
Antibody
Immune checkpoint
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta Announces Participation in Upcoming October 2022 Investor Conferences

Added to Collection on: 2022-10-10 10:36:39

Tags for this article:

U.S. Securities and Exchange Commission
Agencies of the United States government
SEC filings
73rd United States Congress
Financial markets
Securities Act
Prospectus
Forward-looking statement
Securities regulation in the United States
Corporate governance
Proxy statement
Registration statement
Kineta Inc.

Click the tags to see associated articles and topics

View Article Details
Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda | BioSpace

Added to Collection on: 2022-10-17 16:33:52

Tags for this article:

Medicine
Clinical medicine
Immune system
Cancer treatments
Checkpoint inhibitor
Pembrolizumab
Programmed cell death protein 1
VISTA
Tumor microenvironment
C-Met
Cancer immunotherapy
Kineta Inc.
Merck

Click the tags to see associated articles and topics

View Article Details